Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewArformoterol tartrate
Description: Long-acting β2 agonist (LABA)
Chemical Name: N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate
Purity: ≥98% (HPLC)
Biological Activity for Arformoterol tartrate
Arformoterol tartrate is a long-acting β2 adrenergic agonist (LABA). Bronchodilator.
Compound Libraries for Arformoterol tartrate
Arformoterol tartrate is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.
Technical Data for Arformoterol tartrate
| M. Wt | 494.49 |
| Formula | C19H24N2O4.C4H6O6 |
| Storage | Store at +4°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 200815-49-2 |
| PubChem ID | 9827062 |
| InChI Key | FCSXYHUNDAXDRH-OKMNHOJOSA-N |
| Smiles | O[C@@H](C(O)=O)[C@H](C(O)=O)O.COC1=CC=C(C=C1)C[C@H](NC[C@@H](C2=CC(NC=O)=C(C=C2)O)O)C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for Arformoterol tartrate
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 49.45 | 100 | |
| water | 9.89 | 20 |
Preparing Stock Solutions for Arformoterol tartrate
The following data is based on the product molecular weight 494.49. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.02 mL | 10.11 mL | 20.22 mL |
| 5 mM | 0.4 mL | 2.02 mL | 4.04 mL |
| 10 mM | 0.2 mL | 1.01 mL | 2.02 mL |
| 50 mM | 0.04 mL | 0.2 mL | 0.4 mL |
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets for Arformoterol tartrate
References for Arformoterol tartrate
References are publications that support the biological activity of the product.
Op't Holt et al (2007) Inhaled beta agonists. Respir.Care 52 820 PMID: 17594727
If you know of a relevant reference for Arformoterol tartrate, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Arformoterol tartrate, Arformoterol tartrate supplier, B2, Beta2, β2, adrenergic, agonists, agonism, long-acting, LABA, Bronchodilator, Adrenergic, Beta-2, Receptors, 6219, Tocris Bioscience
Citations for Arformoterol tartrate
Citations are publications that use Tocris products.
Currently there are no citations for Arformoterol tartrate. Do you know of a great paper that uses Arformoterol tartrate from Tocris? Please let us know.
Reviews for Arformoterol tartrate
There are currently no reviews for this product. Be the first to review Arformoterol tartrate and earn rewards!
Have you used Arformoterol tartrate?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.